rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2002-5-15
|
pubmed:abstractText |
To correlate renal calculi and other clinical factors with urinary biochemical analytes in patients with inflammatory bowel disease, and to investigate the relative importance of hyperoxaluria (associated with fat malabsorption) or reduced stone inhibitors in the development of calculi in these patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1464-4096
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
835-41
|
pubmed:dateRevised |
2006-7-18
|
pubmed:meshHeading |
pubmed-meshheading:12010224-Acute-Phase Proteins,
pubmed-meshheading:12010224-Adult,
pubmed-meshheading:12010224-Aged,
pubmed-meshheading:12010224-C-Reactive Protein,
pubmed-meshheading:12010224-Citrates,
pubmed-meshheading:12010224-Colitis, Ulcerative,
pubmed-meshheading:12010224-Creatinine,
pubmed-meshheading:12010224-Crohn Disease,
pubmed-meshheading:12010224-Female,
pubmed-meshheading:12010224-Humans,
pubmed-meshheading:12010224-Hyperoxaluria,
pubmed-meshheading:12010224-Kidney Calculi,
pubmed-meshheading:12010224-Magnesium,
pubmed-meshheading:12010224-Malabsorption Syndromes,
pubmed-meshheading:12010224-Male,
pubmed-meshheading:12010224-Middle Aged,
pubmed-meshheading:12010224-Oxalates,
pubmed-meshheading:12010224-Risk Factors,
pubmed-meshheading:12010224-Serum Albumin
|
pubmed:year |
2002
|
pubmed:articleTitle |
Risk factors for developing renal stones in inflammatory bowel disease.
|
pubmed:affiliation |
Biochemistry Department and Gastroenterology Unit, Stobhill Hospital, Glasgow, UK. niel.mcconnell@northglasgow.scot.nhs.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|